- Investing Ideas
- Canadian Pharmaceuticals & Biotech Top Stock Picks from Analysts
Canadian Pharmaceuticals & Biotech Top Stock Picks from Analysts
Results
17
Companies which are more than 50% undervalued based on analyst price target.
17 companies
Green Thumb Industries
Market Cap: CA$2.4b
Manufactures, distributes, markets, and sells of cannabis products for medical and adult-use in the United States.
GTII
CA$10.86
7D
1.9%
1Y
44.6%
Verano Holdings
Market Cap: CA$661.7m
Engages in the cannabis business in the United States.
VRNO
CA$9.08
7D
7.3%
1Y
179.4%
Eupraxia Pharmaceuticals
Market Cap: CA$622.6m
A clinical-stage biotechnology company, focuses on the development of products to address therapeutic areas with unmet medical need.
EPRX
CA$9.53
7D
1.9%
1Y
25.4%
Cresco Labs
Market Cap: CA$526.8m
Cresco Labs Inc. cultivates, manufactures, and sells retail and medical cannabis products in the United States and Germany.
CL
CA$1.16
7D
0%
1Y
70.6%
Spectral Medical
Market Cap: CA$390.2m
Focuses on the development and commercialization of products for the treatment of septic shock in the United States, Italy, Ireland, Russia, and internationally.
EDT
CA$1.33
7D
0.8%
1Y
62.2%
TerrAscend
Market Cap: CA$339.5m
TerrAscend Corp. cultivates, produces, and sells cannabis products in Canada and the United States.
TSND
CA$0.91
7D
-1.1%
1Y
133.3%
High Tide
Market Cap: CA$285.6m
Engages in the cannabis retail business in Canada, the United States, and internationally.
HITI
CA$3.25
7D
0.3%
1Y
4.8%
Organigram Global
Market Cap: CA$204.1m
Engages in the production and sale of cannabis and cannabis-derived products in Canada.
OGI
CA$1.45
7D
-0.7%
1Y
-23.7%
Cardiol Therapeutics
Market Cap: CA$176.4m
A clinical-stage life sciences company, focuses on the development of anti-fibrotic and anti-inflammatory therapies for the treatment of heart diseases.
CRDL
CA$1.53
7D
2.7%
1Y
-22.3%
HLS Therapeutics
Market Cap: CA$131.4m
A specialty pharmaceutical company, acquires and commercializes pharmaceutical products for the treatment of psychiatric disorders and cardiovascular disease in Canada, the United States, and internationally.
HLS
CA$4.20
7D
-1.4%
1Y
-13.9%
Decibel Cannabis
Market Cap: CA$66.4m
An integrated cannabis company, engages in the cannabis cultivation, processing, and sale of cannabis flower products in Canada.
DB
CA$0.12
7D
-4.2%
1Y
53.3%
Vext Science
Market Cap: CA$55.7m
Through its subsidiaries, engages in integrated cannabis operations in the United States.
VEXT
CA$0.23
7D
-6.3%
1Y
45.2%
Sernova Biotherapeutics
Market Cap: CA$49.1m
Operates as a clinical-stage biotechnology company in Canada.
SVA
CA$0.13
7D
-3.7%
1Y
-18.8%
Optimi Health
Market Cap: CA$40.2m
Operates as a pharmaceutical and nutraceutical drug manufacturing company in Canada.
OPTI
CA$7.15
7D
12.6%
1Y
58.9%
Medicenna Therapeutics
Market Cap: CA$36.5m
A clinical-stage immunotherapy company, engages in the development and commercialization of Superkines and empowered Superkines for the treatment of cancer, inflammation, and immune-mediated diseases.
MDNA
CA$0.40
7D
1.3%
1Y
-54.1%
Rubicon Organics
Market Cap: CA$30.7m
Engages in the production, processing, and sale of organic cannabis for the recreational and medical-use markets in Canada and internationally.
ROMJ
CA$0.46
7D
1.1%
1Y
-12.5%
Delivra Health Brands
Market Cap: CA$3.4m
Through its subsidiaries, engages in the health and wellness consumer packaged goods business worldwide.
DHB
CA$0.11
7D
10.0%
1Y
-56.0%